The nurse receives report that a patient has an elevated trough serum level of a medication. Which priority provider order should the nurse anticipate?

Choice A rationale The trough level, typically drawn just before the next dose, measures the lowest concentration of the drug in the bloodstream. An elevated trough indicates drug accumulation and risk of toxicity. The peak level, measured at the highest concentration, is generally not needed after an elevated trough, and a repeat peak would not address the immediate concern of potential toxicity. Choice B rationale Increasing the dose of the medication would lead to an even higher trough level and peak level, significantly elevating the risk of drug toxicity, as the current dose is already causing accumulation (evidenced by the high trough). Therapeutic drug monitoring (TDM) is used to prevent toxicity and maintain efficacy; therefore, a higher dose is contraindicated. Choice C rationale An elevated trough serum level (normal range varies by drug, but often <2 mcg/mL for vancomycin) signifies that the drug is being eliminated too slowly or the interval between doses is too short, leading to accumulation and an increased risk of toxicity. Reducing the dose or lengthening the dosing interval is the priority action to bring the trough level back into the therapeutic range and prevent organ damage. Choice D rationale Many medications, especially renally-excreted ones, have levels affected by kidney function. While obtaining a creatinine level (normal range &sim;0.6-1.2 mg/dL) or estimated Glomerular Filtration Rate (eGFR) is important for assessing drug clearance and adjusting future dosing, the priority immediate intervention is to modify the existing dose regimen to prevent acute toxicity from the current high level.